Literature DB >> 10978341

The mechanism of action of inhibitors of bacterial two-component signal transduction systems.

K Stephenson1, Y Yamaguchi, J A Hoch.   

Abstract

Two-component signal transduction systems allow bacteria to sense and respond rapidly to changes in their environment leading to specific gene activation or repression. These two-component systems are integral in the ability of pathogenic bacteria to mount and establish a successful infection within the host and, consequently, have been recognized as targets for new anti-microbial agents. In this paper, we define the site and mechanism of action of several previously identified inhibitors of bacterial two-component systems. We show that the most potent inhibitors target the carboxyl-terminal catalytic domain of the sensor kinase and exert their affect by causing structural alterations of the kinase leading to aggregation. Recognition of this phenomenon has important implications for the development of novel inhibitors of two-component systems and should facilitate the rapid identification and elimination of compounds with nonspecific affects from medicinal chemistry drug discovery programs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978341     DOI: 10.1074/jbc.M006633200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent.

Authors:  Clare E Blue; Tim J Mitchell
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 2.  Quorum-quenching microbial infections: mechanisms and implications.

Authors:  Y-h Dong; L-y Wang; L-H Zhang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

3.  Quinazoline-Based Antivirulence Compounds Selectively Target Salmonella PhoP/PhoQ Signal Transduction System.

Authors:  María Ayelén Carabajal; Christopher R M Asquith; Tuomo Laitinen; Graham J Tizzard; Lucía Yim; Analía Rial; José A Chabalgoity; William J Zuercher; Eleonora García Véscovi
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  New class of competitive inhibitor of bacterial histidine kinases.

Authors:  Raymond Gilmour; J Estelle Foster; Qin Sheng; Jonathan R McClain; Anna Riley; Pei-Ming Sun; Wai-Leung Ng; Dalai Yan; Thalia I Nicas; Kenneth Henry; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 5.  Roles of two-component regulatory systems in antibiotic resistance.

Authors:  Aimee Rp Tierney; Philip N Rather
Journal:  Future Microbiol       Date:  2019-05-08       Impact factor: 3.165

6.  A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.

Authors:  Michael T Guarnieri; Brian S J Blagg; Rui Zhao
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

7.  The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.

Authors:  Thibaut Boibessot; Christopher P Zschiedrich; Alexandre Lebeau; David Bénimèlis; Catherine Dunyach-Rémy; Jean-Philippe Lavigne; Hendrik Szurmant; Zohra Benfodda; Patrick Meffre
Journal:  J Med Chem       Date:  2016-09-26       Impact factor: 7.446

Review 8.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

9.  Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production.

Authors:  Sarah Underwood; Shuang Guan; Vinod Vijayasubhash; Simon D Baines; Luke Graham; Richard J Lewis; Mark H Wilcox; Keith Stephenson
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

10.  Mechanistic insight into inhibition of two-component system signaling.

Authors:  Samson Francis; Kaelyn E Wilke; Douglas E Brown; Erin E Carlson
Journal:  Medchemcomm       Date:  2012-11-21       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.